Annual EBITDA
-$28.00 M
+$8.27 M+22.80%
December 31, 2023
Summary
- As of February 7, 2025, IMNM annual EBITDA is -$28.00 million, with the most recent change of +$8.27 million (+22.80%) on December 31, 2023.
- During the last 3 years, IMNM annual EBITDA has fallen by -$10.96 million (-64.28%).
- IMNM annual EBITDA is now -289.81% below its all-time high of -$7.18 million, reached on December 31, 2018.
Performance
IMNM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$43.24 M
-$10.22 M-30.95%
September 30, 2024
Summary
- As of February 7, 2025, IMNM quarterly EBITDA is -$43.24 million, with the most recent change of -$10.22 million (-30.95%) on September 30, 2024.
- Over the past year, IMNM quarterly EBITDA has dropped by -$29.65 million (-218.12%).
- IMNM quarterly EBITDA is now -1635.35% below its all-time high of -$2.49 million, reached on March 31, 2020.
Performance
IMNM Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$109.94 M
-$38.78 M-54.49%
September 30, 2024
Summary
- As of February 7, 2025, IMNM TTM EBITDA is -$109.94 million, with the most recent change of -$38.78 million (-54.49%) on September 30, 2024.
- Over the past year, IMNM TTM EBITDA has dropped by -$81.94 million (-292.66%).
- IMNM TTM EBITDA is now -4184.68% below its all-time high of -$2.57 million, reached on September 30, 2019.
Performance
IMNM TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
IMNM EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.8% | -218.1% | -292.7% |
| 3 y3 years | -64.3% | -474.5% | -203.1% |
| 5 y5 years | -289.8% | -474.5% | -203.1% |
IMNM EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -14.5% | +22.8% | -900.4% | at low | -401.3% | at low |
| 5 y | 5-year | -188.0% | +22.8% | -1635.3% | at low | -1981.1% | at low |
| alltime | all time | -289.8% | +22.8% | -1635.3% | at low | -4184.7% | at low |
Immunome EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$43.24 M(+31.0%) | -$109.94 M(+54.5%) |
| Jun 2024 | - | -$33.02 M(+64.4%) | -$71.17 M(+62.6%) |
| Mar 2024 | - | -$20.08 M(+47.7%) | -$43.76 M(+56.3%) |
| Dec 2023 | -$28.00 M(-22.8%) | -$13.59 M(+204.3%) | -$28.00 M(+27.7%) |
| Sep 2023 | - | -$4.47 M(-20.5%) | -$21.93 M(-15.3%) |
| Jun 2023 | - | -$5.62 M(+29.9%) | -$25.89 M(-11.0%) |
| Mar 2023 | - | -$4.32 M(-42.6%) | -$29.07 M(-19.8%) |
| Dec 2022 | -$36.27 M(+48.3%) | -$7.53 M(-10.6%) | -$36.27 M(-0.5%) |
| Sep 2022 | - | -$8.42 M(-4.4%) | -$36.47 M(+2.8%) |
| Jun 2022 | - | -$8.80 M(-23.6%) | -$35.49 M(+10.0%) |
| Mar 2022 | - | -$11.52 M(+49.1%) | -$32.25 M(+31.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$24.45 M(+43.4%) | -$7.73 M(+3.9%) | -$24.45 M(+19.1%) |
| Sep 2021 | - | -$7.44 M(+33.6%) | -$20.53 M(-3.5%) |
| Jun 2021 | - | -$5.57 M(+49.6%) | -$21.28 M(+16.5%) |
| Mar 2021 | - | -$3.72 M(-2.2%) | -$18.27 M(+7.2%) |
| Dec 2020 | -$17.04 M(+75.3%) | -$3.81 M(-53.5%) | -$17.04 M(+6.8%) |
| Sep 2020 | - | -$8.19 M(+220.4%) | -$15.96 M(+54.4%) |
| Jun 2020 | - | -$2.56 M(+2.6%) | -$10.33 M(+32.9%) |
| Mar 2020 | - | -$2.49 M(-8.3%) | -$7.78 M(+47.2%) |
| Dec 2019 | -$9.72 M(+35.4%) | -$2.72 M(+5.9%) | -$5.28 M(+105.9%) |
| Sep 2019 | - | -$2.57 M | -$2.57 M |
| Dec 2018 | -$7.18 M | - | - |
FAQ
- What is Immunome annual EBITDA?
- What is the all time high annual EBITDA for Immunome?
- What is Immunome annual EBITDA year-on-year change?
- What is Immunome quarterly EBITDA?
- What is the all time high quarterly EBITDA for Immunome?
- What is Immunome quarterly EBITDA year-on-year change?
- What is Immunome TTM EBITDA?
- What is the all time high TTM EBITDA for Immunome?
- What is Immunome TTM EBITDA year-on-year change?
What is Immunome annual EBITDA?
The current annual EBITDA of IMNM is -$28.00 M
What is the all time high annual EBITDA for Immunome?
Immunome all-time high annual EBITDA is -$7.18 M
What is Immunome annual EBITDA year-on-year change?
Over the past year, IMNM annual EBITDA has changed by +$8.27 M (+22.80%)
What is Immunome quarterly EBITDA?
The current quarterly EBITDA of IMNM is -$43.24 M
What is the all time high quarterly EBITDA for Immunome?
Immunome all-time high quarterly EBITDA is -$2.49 M
What is Immunome quarterly EBITDA year-on-year change?
Over the past year, IMNM quarterly EBITDA has changed by -$29.65 M (-218.12%)
What is Immunome TTM EBITDA?
The current TTM EBITDA of IMNM is -$109.94 M
What is the all time high TTM EBITDA for Immunome?
Immunome all-time high TTM EBITDA is -$2.57 M
What is Immunome TTM EBITDA year-on-year change?
Over the past year, IMNM TTM EBITDA has changed by -$81.94 M (-292.66%)